Back to Research Hub
Glaukos Corporation
GKOS
$126.34+4.38 (+3.59%)
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
StreetsValue research for Glaukos Corporation (GKOS)
Members get the full report for Glaukos Corporation: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.